You are here

United Nations

Paxlovid Cuts Covid Death Risk. But Useage is Low --studies

As Covid rises again, killing about 1,500 Americans each week, medical researchers are trying to understand why so few people are taking Paxlovid, a medicine that is stunningly effective in preventing severe illness and death from the disease.

ALSO SEE: Less than a third of high-risk COVID outpatients prescribed antivirals, study finds

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

JN.1 designated by WHO as separate COVID-19 variant of interest

Due to its rapid growth and potential to add to the respiratory virus burden in Northern Hemisphere countries, the World Health Organization (WHO) today designated JN.1, part of the BA.2.86 SARS-CoV-2 lineage, as its own variant of interest.

Over the past month, the proportion of JN.1 viruses has rapidly increased, rising from 3.3% in early November to 27.1% by early December. Countries reporting the highest proportions include France, the United States, Singapore, Canada, and the United Kingdom.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to United Nations
howdy folks